Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction

Eur Heart J Cardiovasc Imaging. 2017 Jul 1;18(7):725-729. doi: 10.1093/ehjci/jex038.

Abstract

Aims: To determine if markers of diastolic dysfunction are associated with atrial fibrillation (AF) development among patients with heart failure with preserved ejection fraction (HFpEF).

Methods and results: We examined the association of several echocardiographic measures of diastolic dysfunction with incident AF in 573 patients (mean age = 68 ± 9.5 years; 48% men; 79% white) with HFpEF from the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial (TOPCAT) who were free of baseline AF. Echocardiograms were analysed at a core laboratory. Incident AF cases were identified by follow-up study electrocardiograms and review of relevant medical records through May of 2013. Over a median follow-up of 3 years, 40 patients developed AF (incidence rate = 2.2 per 100 person years). Increasing values of the E/A ratio [per 0.1 increase: hazard ratio (HR) = 1.11, 95% confidence interval (CI) = 1.06-1.17], left atrial volume (per 5 mL increase: HR = 1.13, 95% CI = 1.03-1.23), and left atrial area (per 5 cm2 increase: HR = 1.51, 95% CI = 1.03-2.22) were associated with greater risk of AF. The risk of AF decreased with increasing peak A wave velocities (per 10 cm/s increase: HR = 0.83, 95% CI = 0.72-0.96). The risk of AF was not materially altered when peak A wave velocity was further adjusted for left atrial volume (HR = 0.83, 95% CI = 0.71-0.96) and area (HR = 0.83, 95% CI = 0.71-0.96). However, the associations of left atrial volume (HR = 1.10, 95% CI = 0.99-1.22) and area (HR = 1.48, 95% CI = 0.96-2.28) were no longer significant when accounting for peak A wave velocity.

Conclusion: Diastolic parameters of left atrial function possibly are more important markers of AF risk than left atrial dilation in HFpEF.

Keywords: atrial fibrillation; echocardiogram; heart failure; preserved ejection fraction.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Atrial Fibrillation / diagnostic imaging
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / epidemiology*
  • Comorbidity
  • Double-Blind Method
  • Echocardiography, Doppler / methods*
  • Female
  • Heart Failure / diagnostic imaging
  • Heart Failure / drug therapy
  • Heart Failure / epidemiology*
  • Humans
  • Incidence
  • Internationality
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Spironolactone / therapeutic use
  • Stroke Volume / physiology*
  • Survival Analysis

Substances

  • Spironolactone